Hospitalization and mortality rates for heart failure in public hospitals in são paulo

Arquivos Brasileiros de Cardiologia

Volumn 97, Issue 5, 2011, Pages 402-407

  Godoy, Henrique L ^a   Silveira, José A ^a   Segalla, Eduardo ^a   Almeida, Dirceu R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Heart failure mortality; Hospitalization; Hospitals; Municipal; Public

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; DEATH; FEMALE; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PUBLIC HEALTH SERVICE; SEASONAL VARIATION;

AGED; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; MALE; MIDDLE AGED; SEASONS;

EID: 84455175884     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000096     Document Type: Article

References (24)

1. Moraes SA, Suzuki CS, Freitas IC, Costa ML. Mortalidade por doenças do aparelho circulatório no município de Ribeirão Preto, de 1980-2004. Arq Bras Cardiol. 2009;93(6):637-44.
2. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5(2):167-73.
3. Ministério da Saúde. DATASUS. Sistema de informação sobre mortalidade, 1979-1997. Dados de declaração de óbito. [Acesso em 2010 nov 20]. Disponível em www.datasus.gov.br, 2006.
4. Solvd investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327(10):685-91.
5. Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341(10):709-17.
6. Hjalmarson A, Goldstein S, Fagerberg B, Wedel W, Waagstein F, Kjekshus J, et al. Effects of controlled release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT HF Study Group. JAMA. 2000;283(10):1295-302.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-83.
8. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin - converting-enzyme inhibitors: the CHARM-Alternative Trial. Lancet. 2003;362(9386):772-6.
9. O'connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, et al. Causes of death and rehospitalization in patients with worsening heart failure and reduced left ventricular ejection fraction: results from efficacy of vasopressin antagonist in heart failure outcome study with tolvaptan program. Am Heart J. 2010;159(5):841-9.e1
10. Abrahan WT, Trupp RJ, Jarjoura D. Nesiritide in acute decompesated heart failure: a pooled analysis of randomized clinical trials. Clin Cardiol. 2010;33(8):484-9.
11. Bocchi EA, Marcondes-Braga FG, Ayub-Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, et al./Sociedade Brasileira de Cardiologia. III Diretriz brasileira de insuficiência cardíaca crônica. Arq Bras Cardiol. 2009;93(1 supl.1):1-71.
12. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26(16):1653-9.
13. Komajda M, Bourhour JB, Amouyel P, Delahaye F, Vicaut E, Croce I, et al. Ambulatory heart failure management in private practice in France. Eur J Heart Fail. 2001;3(4):502-7.
14. Taubert G, Bergmeier C, Andresen H, Senges J, Potratz J. Clinical profile and management of heart failure: rural community hospital vs metropolitan heart center. Eur J Heart Fail. 2001;3(5):611-7.
15. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure. J Am Coll Cardiol. 2008;52(20):1640-8.
16. Baliero HM, Osugue RK, Rangel SP, Brandão R, Baileiro TL, Bernardez S, et al. Clinical and demographic profile and quality indicators for heart failure at a rural area. Arq Bras Cardiol. 2009;93(6):637-42.
17. Bueno H, Ross J, Wang Y, Chen J, Vidán MT, Normand SL, et al. Trends in length of stay and short-term outcomes among patients hospitalized for heart failure, 1993-2006. JAMA. 2010;303(21):2141-7.
18. Abrahan WT, Fonarow G, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52(5):347-56.
19. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments and outcomes for heart failure hospitalizations 2002-2004: findings from Acute decompensated Heart Failure Registry (ADHERE). Am Heart J. 2007;153(6):1021-8.
20. Get with The Guidelines Heart Failure. [Access in 2010 nov 20]. Available at http://www.heart.org/HEARTORG/HealthcareProfessional/GetWithTheGuidelinesHFStrok, 2010.
21. Stewart S, McIntyre K, Capewell S, McMurray JJ. Heart failure and cold climate. Seasonal variation in heart failure related mortality. J Am Coll Cardiol. 2002;39(5):760-6.
22. Boulay F, Berthier F, Sisteron O, Grendeike Y, Gibelin P. Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation. 1999;100(3):280-6.
23. Cold exposure and winter mortality from ischemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. Lancet. 1997;349(9062):1341-6.
24. Argiles A, Mourad G, Mion C. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis. N Engl J Med. 1998;339(19):1364-70.